Status:
UNKNOWN
A RCT Study in Schizophrenia Relapse Prevention
Lead Sponsor:
Prague Psychiatric Center
Conditions:
Relapse Schizophrenia
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
THE AIM OF THE PROJECT The main aim lies in the prevention of frequent relapses typical for schizophrenia and schizoaffective disorder by means of simple, highly cost-effective information technology-...
Detailed Description
The ITAREPS 2.0 program employs telecommunication and information technologies in order to detect fluctuations in longitudinal mental health status of patient with schizophrenia and thus signalize the...
Eligibility Criteria
Inclusion
- For entry into the study, the following criteria MUST be met:
- Men and women, ages 18 to 60 years, inclusive.
- A diagnosis of schizophrenia or schizoaffective disorder according to ICD-10 classification.
- Having at least TWO psychiatric hospitalization for psychosis before the study enrollment.
- Severity (CGI-S) ≤ 3 at study Visit 1.
- All patients must be on stable doses of antipsychotic medication during the study entry.
Exclusion
- Organic mental disorder,
- mental disorder due to psychoactive substance use or mental retardation.
- Participation in another relapse prevention program.
- Hayward compliance rating scale score \< 2 at Visit 1.
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01885923
Start Date
August 1 2012
End Date
December 1 2015
Last Update
July 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prague Psychiatric Center
Prague, Czechia, 18103